6-[18F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma
暂无分享,去创建一个
Graeme Eisenhofer | David S. Goldstein | Jorge A. Carrasquillo | Karel Pacak | D. Goldstein | J. Carrasquillo | K. Pacak | Clara C. Chen | G. Eisenhofer | Sheng-Ting Li | Sheng-Ting Li | Sheng‐Ting Li | D. Goldstein
[1] D. Kuhl,et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] D. Goldstein,et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. , 1990, Circulation.
[3] P. Herscovitch,et al. Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. , 1993, Journal of the American College of Cardiology.
[4] L. Quint,et al. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. , 1987, Radiology.
[5] M. Walther,et al. Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[6] I. Francis,et al. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. , 1999, Radiology.
[7] K. Usadel,et al. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours , 1997, European Journal of Nuclear Medicine.
[8] W. Beierwaltes,et al. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] B. Shulkin,et al. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors. , 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[10] W. Linehan,et al. Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma , 2001, Annals of Internal Medicine.
[11] J. Pool,et al. Localization of ectopic pheochromocytomas by magnetic resonance imaging. , 1987, The American journal of medicine.
[12] M. Salvatore,et al. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. , 1996, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[13] J. Sisson,et al. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas. , 1985, Surgery.
[14] J. Lenders,et al. Plasma Metanephrines in the Diagnosis of Pheochromocytoma , 1995, Annals of Internal Medicine.